Skip to main content
Top
Published in: Indian Journal of Gastroenterology 5/2015

01-09-2015 | Letter

Short sleep duration of overweight and obese patients with erosive esophagitis and gastritis

Authors: Levent Filik, Nur Ozer

Published in: Indian Journal of Gastroenterology | Issue 5/2015

Login to get access

Excerpt

Current knowledge states that there is a strong relationship between sleep disturbances and gastroesophageal reflux either erosive or nonerosive [1]. On the other hand, high body mass index (BMI) is known to cause sleep disorders as well [2]. However, there is not enough data that determine the association of both high BMI and sleep disturbance in patients with erosive esophagitis and nonreflux dyspepsia. In this regard, we asked our patients if they did complain from short sleep duration in February 2015. Consecutive 44 (M 16, F 28) patients with erosive esophagitis and 51 (M 19, F 32) patients with gastritis were recruited for the study. The diagnosis was put via upper gastrointestinal endoscopy. The patients were between 20 and 50 years of age. BMI were calculated with present weight and length at current gastroenterology admission. Patients were asked if they had short sleep duration (6 h/day) in the last month. BMI ≥30 was determined as obesity. BMI ≥25 was accepted as overweight [3]. Distribution of presence of obesity and short sleep duration in patient groups is seen in Table 1. There was a statistically significant relationship between short sleep duration and presence of either gastritis or reflux regardless of BMI (p < 0.05) (Table 1). Accordingly, short sleep duration was more frequent in either overweight or obese patients (Table 2). In conclusion, overall both reflux esophagitis and gastritis were associated with short sleep duration. Also, this association was statistically significant in the presence of high BMI. We suggest that further studies are necessary to clarify the impact of high BMI on the several types of sleep disturbances in patients with reflux esophagitis or gastritis.
Table 1
Distribution of overall patients data
 
All patients
Short sleep
Normal sleep
p
Age (year)
44 ± 11
46 ± 11
43 ± 11
0.38
Reflux esophagitis n (%)
44 (46)
24 (61)
20 (36)
0.01
Gastritis n (%)
51 (54)
15 (39)
36 (64)
0.01
Body mass index
28 ± 5
28 ± 5
27 ± 5
0.44
Table 2
Relationship between body mass index, short sleep, and presence of reflux or gastritis
 
All
Short sleep
Normal sleep
p
Reflux esophagitis and BMI <30, n (%)
27 (46)
12 (54)
15 (40)
0.42
Reflux esophagitis and BMI ≥30, n (%)
17 (47)
12 (71)
5 (26)
0.008
Gastritis BMI <30, n (%)
32 (54)
10 (45)
22 (60)
0.29
Gastritis BMI ≥30, n (%)
19 (53)
5 (29)
14 (74)
0.008
Reflux esophagitis and BMI <25, n (%)
11 (42)
4 (44)
7 (41)
0.9
Reflux esophagitis and BMI ≥25, n (%)
33 (48)
20 (67)
13 (33)
0.006
Gastritis BMI <25, n (%)
15 (58)
5 (56)
10 (59)
0.9
Gastritis BMI ≥25, n (%)
36 (52)
10 (33)
26 (67)
0.006
BMI body mass index
Literature
1.
go back to reference Murase K, Tabara Y, Takahashi Y, et al. Gastroesophageal reflux disease symptoms and dietary behaviours are significant correlates of short sleep duration in the general people: the Nagahama study. Sleep. 2014;37:1809–15.PubMedCentralPubMed Murase K, Tabara Y, Takahashi Y, et al. Gastroesophageal reflux disease symptoms and dietary behaviours are significant correlates of short sleep duration in the general people: the Nagahama study. Sleep. 2014;37:1809–15.PubMedCentralPubMed
2.
go back to reference Kirkness JO. Obesity-related ventilatory phenotypes of sleep-disordered breathing. Am J Respir Crit Care Med. 2014;190:853–4.CrossRefPubMed Kirkness JO. Obesity-related ventilatory phenotypes of sleep-disordered breathing. Am J Respir Crit Care Med. 2014;190:853–4.CrossRefPubMed
3.
go back to reference Flegal KM, Carroll MD, Kucmaski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22:39–47.CrossRefPubMed Flegal KM, Carroll MD, Kucmaski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998;22:39–47.CrossRefPubMed
Metadata
Title
Short sleep duration of overweight and obese patients with erosive esophagitis and gastritis
Authors
Levent Filik
Nur Ozer
Publication date
01-09-2015
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 5/2015
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-015-0601-4

Other articles of this Issue 5/2015

Indian Journal of Gastroenterology 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.